Crown Reserve Acquisition Corp. I (CRAC) Stock Analysis

AI analysis of Crown Reserve Acquisition Corp. I (CRAC)

Hold

Crown Reserve Acquisition Corp. I (CRAC) is currently priced at 10.27, which is just below its 52-week high of 10.30, indicating limited upside potential. The RSI is at 54.98, suggesting the stock is neither overbought nor oversold, which is neutral. However, the forward P/E ratio is 0, indicating uncertainty about future earnings, and the current ratio is low at 0.03, which raises concerns about liquidity. The stock has shown a year-to-date change of +3.32%, but with no significant positive catalysts or insider buying activity, it may be prudent to hold rather than buy at this time.

Valuation Metrics

The current forward P/E ratio for Crown Reserve Acquisition Corp. I (CRAC) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E

Current P/E

0.00

Forward EV/EBITDA

5Y Average EV/EBITDA

Current EV/EBITDA

0.00

Forward P/S

5Y Average P/S

Current P/S

0.00

Whales holding CRAC

W

W. R. Berkley Corporation

+ HoldingCRAC

-1.34%

3M Return

P

Polar Asset Management Partners Inc.

+ HoldingCRAC

-2.91%

3M Return

CRAC FAQ — answered by Alphio AI

Crown Reserve Acquisition Corp I is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focused industries include pharma, medical technology and medical equipment, and healthcare information technology (IT) industries. The Company is not engaged in any business operation and does not have any revenues. It operates in the Financials sector.

Crown Reserve Acquisition Corp. I (CRAC) is currently priced at 10.27, which is just below its 52-week high of 10.30, indicating limited upside potential. The RSI is at 54.98, suggesting the stock is neither overbought nor oversold, which is neutral. However, the forward P/E ratio is 0, indicating uncertainty about future earnings, and the current ratio is low at 0.03, which raises concerns about liquidity. The stock has shown a year-to-date change of +3.32%, but with no significant positive catalysts or insider buying activity, it may be prudent to hold rather than buy at this time.